Skip to ContentSkip to Navigation
How to find us dr. W.M. (W Martin) Smid


Use of COVID-19 convalescent plasma in low- and middle-income countries: a call for ethical principles and the assurance of quality and safety

Plasma-based COVID-19 treatments in low- and meddle-income countries and the risk of transfusion-transmitted infections.

Points to consider in the preparation and transfusion of COVID-19 convalescent plasma in low- and middle- income countries

False-positive viral marker results in blood donors and their unintended consequences: P. Kiely, VC Hoad, EM Wood

Apheresis in developing countries around the World

Positive HBV-NAT in a blood donor 11 years after HBV vaccination

Renal transplantation in patients with atypical haemolytic uraemic syndrome: a tailor made approach is necessary

Lymphocyte subset abnormalities in multitransfused HIV-negative haemophilia A patients are not due to chronic hepatitis C virus infection

Low-molecular-weight heparin in the treatment of patients with venous thromboembolism

Natural history of hepatitis C in HIV-negative patients with congenital coagulation disorders

Read more